Intelligent Bio Solutions Inc (INBS)

Mar 31, 2025, 8:30 AM EDT - 3 days ago

Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System

Mar 28, 2025, 8:30 AM EDT - 6 days ago

Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show

Mar 27, 2025, 9:00 AM EDT - 7 days ago

Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra

Mar 26, 2025, 8:30 AM EDT - 8 days ago

Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry

Mar 25, 2025, 9:00 AM EDT - 9 days ago

Intelligent Bio Solutions' FDA Clearance Process Remains on Track for 2025 U.S. Launch

Mar 20, 2025, 8:30 AM EDT - 14 days ago

Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant

Mar 11, 2025, 8:30 AM EDT - 23 days ago

Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th

Feb 21, 2025, 4:05 PM EST - 5 weeks ago

Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter's Option to Purchase Additional Shares of Common Stock

Feb 20, 2025, 8:30 AM EST - 6 weeks ago

Intelligent Bio Solutions Inc. Announces Pricing of $2.6 Million Public Offering of Common Stock

Feb 19, 2025, 4:42 PM EST - 6 weeks ago

Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock

Feb 13, 2025, 8:30 AM EST - 7 weeks ago

Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements

Feb 10, 2025, 8:30 AM EST - 7 weeks ago

Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy

Feb 7, 2025, 8:30 AM EST - 7 weeks ago

Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch

Feb 6, 2025, 9:00 AM EST - 2 months ago

Intelligent Bio Solutions expects to achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales

Jan 31, 2025, 9:00 AM EST - 2 months ago

Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade

Jan 29, 2025, 9:00 AM EST - 2 months ago

Intelligent Bio Solutions Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing

Jan 14, 2025, 8:30 AM EST - 2 months ago

Intelligent Bio Solutions Partners with Princebuild to Transition from Saliva Testing to Fingerprint Sweat-Based Drug Screening Across its Seven UK Sites

Dec 18, 2024, 8:30 AM EST - 3 months ago

Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology

Dec 4, 2024, 8:30 AM EST - 4 months ago

Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET

Nov 21, 2024, 8:30 AM EST - 4 months ago

Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference

Oct 31, 2024, 8:30 AM EDT - 5 months ago

Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach

Oct 29, 2024, 8:30 AM EDT - 5 months ago

Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results

Oct 16, 2024, 8:00 AM EDT - 6 months ago

Intelligent Bio Solutions to Present at the LD Micro Main Event XVII on October 28-30 in Los Angeles

Oct 14, 2024, 8:00 AM EDT - 6 months ago

Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek

Oct 9, 2024, 8:30 AM EDT - 6 months ago

Intelligent Bio Solutions Partners with Spirit Group as Australian Distributor, Expanding Community Impact with Intelligent Fingerprinting Drug Testing Solution

Oct 1, 2024, 8:30 AM EDT - 6 months ago

GPS Marine Adopts Intelligent Bio Solutions' Fingerprint Drug Testing Technology to Boost Workplace Safety in Maritime Services

Sep 27, 2024, 8:30 AM EDT - 6 months ago

Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission

Sep 25, 2024, 8:30 AM EDT - 6 months ago

UK's Largest Greenhouse Complex, Thanet Earth, Adopts Intelligent Bio Solutions' Fingerprint Drug Test to Enhance Workplace Safety

Sep 19, 2024, 8:30 AM EDT - 7 months ago

Intelligent Bio Solutions Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Operational Highlights

Sep 11, 2024, 8:30 AM EDT - 7 months ago

Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Virtual Conference on September 18-19, 2024

Sep 10, 2024, 4:01 AM EDT - 7 months ago

Penny stocks analysis: AITX, Intelligent Bio (INBS), Tonix (TNXP)

TNXP

Sep 5, 2024, 8:30 AM EDT - 7 months ago

Intelligent Bio Solutions Inc. Announces Progress Toward Completion of Clinical Study Plan Required for FDA 510(k) Submission

Sep 3, 2024, 8:30 AM EDT - 7 months ago

Intelligent Bio Solutions Inc. Reports 118% Year-Over-Year Growth in Customer Employee Base, Reaching an Estimated Total of 1.4 Million Employees

Aug 21, 2024, 8:30 AM EDT - 8 months ago

Intelligent Bio Solutions Inc. Achieves Major Milestone with Over 1,000 Installed Intelligent Fingerprinting Drug Screening Readers as of June 30, 2024

Aug 20, 2024, 7:00 AM EDT - 8 months ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GDTC GOSS GOVX

Aug 13, 2024, 8:30 AM EDT - 8 months ago

Intelligent Bio Solutions Inc. Highlights Growing Need for Drug Testing Solutions in Key Industries

Aug 1, 2024, 8:30 AM EDT - 8 months ago

Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway

Jul 24, 2024, 8:30 AM EDT - 9 months ago

Intelligent Bio Solutions Inc. Announces QabasTech as Exclusive Distributor in Saudi Arabia

Jul 18, 2024, 8:30 AM EDT - 9 months ago

Intelligent Bio Solutions Inc. Advances on FDA 510(k) Pathway with Biocompatibility Study Success

Jun 28, 2024, 8:30 AM EDT - 9 months ago

Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results

Jun 27, 2024, 8:30 AM EDT - 10 months ago

Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions

Jun 18, 2024, 8:30 AM EDT - 10 months ago

Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology

Jun 12, 2024, 8:30 AM EDT - 10 months ago

Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology

Jun 6, 2024, 8:30 AM EDT - 10 months ago

Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024

May 29, 2024, 8:30 AM EDT - 11 months ago

Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) Study

May 23, 2024, 8:30 AM EDT - 11 months ago

Intelligent Bio Solutions Unveils Key Performance Indicator Growth in the United Kingdom as Drug Screening Industry Combats Drug Test Cheating and Searches for Simpler, Faster, Non-Invasive and More Cost-Effective Solutions

May 17, 2024, 8:30 AM EDT - 11 months ago

Innovative Fingerprint Drug Screening Solution Showcased at the UK's Premier Health and Safety Event

May 8, 2024, 8:30 AM EDT - 11 months ago

Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights

Apr 18, 2024, 8:30 AM EDT - 1 year ago

Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results

Apr 11, 2024, 8:30 AM EDT - 1 year ago

Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge Reader